Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EPS (Weighted Average and Diluted) (2016 - 2026)

Phibro Animal Health has reported EPS (Weighted Average and Diluted) over the past 13 years, most recently at $0.67 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 737.5% year-over-year to $0.67; the TTM value through Dec 2025 reached $2.26, up 370.83%, while the annual FY2025 figure was $1.19, 1883.33% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.67 at Phibro Animal Health, up from $0.65 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.67 in Q4 2025 and troughed at -$0.2 in Q3 2023.
  • A 5-year average of $0.27 and a median of $0.23 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 300.0% in 2023 and later soared 2050.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.43 in 2021, then plummeted by 58.14% to $0.18 in 2022, then tumbled by 83.33% to $0.03 in 2023, then surged by 166.67% to $0.08 in 2024, then soared by 737.5% to $0.67 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PAHC at $0.67 in Q4 2025, $0.65 in Q3 2025, and $0.43 in Q2 2025.